Wafik S. El-Deiry: Targeting apoptotic pathways for cancer therapy
Wafik S. El-Deiry shared a post on LinkedIn:
”Pleased to share our published review article from The Warren Alpert Medical School of Brown University.
Targeting apoptotic pathways for cancer therapy.
Authors: Xiaobing Tian, Praveen Srinivasan, Vida Tajiknia,Ashley Sanchez Sevilla Uruchurtu,Attila Seyhan, Benedito A. Carneiro, Arielle De La Cruz, Maximilian Pinho-Schwermann, Andrew George, Shuai Zhao, Jillian Strandberg,Francesca Di Cristofano, Shengliang Zhang,Lanlan Zhou,Alexander Raufi,Navaraj Arunasalam,Yiqun Zhang,Nataliia Verovkina,Maryam Ghandali,Dinara Ryspayeva, Wafik S. El-Deiry.”
Source: Wafik S. El-Deiry/LinkedIn
Wafik El-Deiry, MD, PhD, FACP, FRSM, is the Associate Dean for Oncologic Sciences at the Warren Alpert Medical School and Director of the Legorreta Cancer Center at Brown University and Director of the Joint Program in Cancer Biology of Brown University and affiliated hospitals.Dr. El-Deiry discovered p21(WAF1) as a p53 target gene, cell cycle inhibitor, and tumor suppressor that explained the mammalian cell stress response. Dr. El-Deiry’s research is focused on mechanisms of therapy resistance with major efforts in drug discovery and development.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023